FDA inspection
Sentry Biopharma Services, Inc.: FDA inspection ending Jun 30, 2016
FDA inspection 977286 · No Action Indicated (NAI) · Indianapolis, IN
Key facts
| Inspection ID | 977286 |
|---|---|
| Firm | Sentry Biopharma Services, Inc. |
| FEI number | 3007066137 |
| Address | 4605 Decatur Blvd |
| City | Indianapolis |
| State | IN |
| ZIP | 46241 |
| Country | United States |
| Fiscal year | 2016 |
| Inspection end date | Jun 30, 2016 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data